GLP-1 receptor agonist use tied to higher NAION risk
Use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) was associated with a modestly increased risk of nonarteritic ischemic optic neuropathy (NAION), according to data from a meta-analysis of more than…